Alnylam Pharmaceuticals, Inc. (ALNY)

296.24 +0.74 (+0.25%) USD  |  NASDAQ  |  May 27, 15:52
More

Alnylam Pharmaceuticals Free Cash Flow : 641.34M for March 31, 2026

Free Cash Flow Chart

View Free Cash Flow for ALNY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Free Cash Flow Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Free Cash Flow Range, Past 5 Years

View Free Cash Flow Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Free Cash Flow Benchmarks

View Free Cash Flow Benchmarks
Start Trial
Aldeyra Therapeutics, Inc. -25.99M
Ionis Pharmaceuticals, Inc. -977.73M
Sarepta Therapeutics, Inc. 91.18M
BridgeBio Pharma, Inc. -452.02M
BioMarin Pharmaceutical, Inc. 759.12M

Free Cash Flow Related Metrics

Cash from Operations (Quarterly) 70.50M
Cash from Investing (Quarterly) -25.54M
Cash from Financing (Quarterly) 15.71M
Free Cash Flow Per Share (Quarterly) 0.3521
Free Cash Flow to Equity (Quarterly) 47.24M
Free Cash Flow to Firm (Quarterly) 113.06M
Free Cash Flow Yield 1.60%